clofibric acid has been researched along with Cholelithiasis in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, MH | 1 |
| Armani, A | 1 |
| McKenney, JM | 1 |
| Jacobson, TA | 1 |
| Reuter, W | 1 |
1 review available for clofibric acid and Cholelithiasis
| Article | Year |
|---|---|
Safety considerations with fibrate therapy.
Topics: Cholelithiasis; Clinical Trials as Topic; Clofibric Acid; Creatinine; Drug Therapy, Combination; Dys | 2007 |
1 other study available for clofibric acid and Cholelithiasis
| Article | Year |
|---|---|
[Current treatment with clofibrate or clofibric acid (Regadrin)].
Topics: Cholelithiasis; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Hyperlipoprot | 1982 |